Maintenance ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, Adjuvant6-MercaptopurineCyclophosphamideCombined Modality TherapyMethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalThioguanineTreatment OutcomeDrug Administration ScheduleEtoposideVincristineCytarabineLung NeoplasmsRemission InductionDaunorubicinAntineoplastic AgentsSurvival AnalysisCisplatinDoxorubicinClinical Trials as TopicLeukemia, LymphoidPrednisoneCarcinoma, Small CellFollow-Up StudiesTime FactorsNeoadjuvant TherapyRecurrenceBreast NeoplasmsNeoplasm StagingPrognosisSurvival RateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmNeoplasmsBleomycinDeoxycytidineAntimetabolites, AntineoplasticOrganoplatinum CompoundsAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionSalvage TherapyCarcinoma, Non-Small-Cell LungOvarian NeoplasmsNeoplasm MetastasisTesticular NeoplasmsTransplantation, AutologousVomitingNeutropeniaAdenocarcinomaNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseColorectal NeoplasmsRadiotherapyProspective StudiesAntibiotics, AntineoplasticDacarbazineKaplan-Meier EstimateCarmustineNeoplasms, Germ Cell and EmbryonalGranulocyte Colony-Stimulating FactorLomustineBrain NeoplasmsCamptothecinPlatinum CompoundsDose-Response Relationship, DrugBone NeoplasmsMelphalanOsteosarcomaMitomycinLeukopeniaInfusions, Intra-ArterialInfusions, IntravenousAntiemeticsHematopoietic Stem Cell TransplantationTumor Markers, BiologicalLiver NeoplasmsThiotepaCell Line, TumorDrug TherapyMitoxantronePeritoneal NeoplasmsAntibodies, Monoclonal, HumanizedLymphatic MetastasisStomach NeoplasmsPalliative CareTegafurRadiotherapy Dosage